课题基金 / 基金详情

COMMUNITY CLINICAL ONCOLOGY PROGRAM

COMMUNITY CLINICAL ONCOLOGY PROGRAM
社区临床肿瘤学计划
批准号:
3557652
负责人:
DAVID K KING
金额:
$8.33万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-09-01 至 1987-05-31

项目摘要

项目成果

DAVID K KING的其他基金

相关文献

中文摘要
翻译
大凤凰城社区临床肿瘤学项目(GPCCOP)代表 由五家医院和五组附属医生组成的财团 大都市凤凰城地区,有31名肿瘤学调查人员 被指定管理临床试验中的患者。该财团认为 每年新增癌症患者人数超过2300人。这个 我们GPCCOP的近期目标包括:增加临床研究 活动;开发和维护数据管理支助 最大限度提高数据质量并支持NCI癌症的网络 对照评价;进一步开发药学资源;以及 继续开展基础广泛的癌症计划,包括原发癌症 护理医生。该财团拥有完善的设施和人员,以 癌症的治疗,并已经实施了联合癌症控制 活动,如医生和护理病人管理指南,在 除了每个项目中存在的广泛的癌症控制活动之外 GPCCOP组件。GPCCOP制定了详细的方法 用于实施临床研究活动。我们已经建立了一个 集中式数据管理系统,协议选择的标准 保证病人收益、医生病人记录、适当的人员配备 收集数据并监控协议遵从性、研究机制 基础数据传输、质量控制和反馈程序、药房 根据FDA和IRB规定的要求进行控制 联络委员会与各个医院的IRBs互动。
英文摘要
The Greater Phoenix Community Clinical Oncology Program (GPCCOP) represents a consortium of five hospitals and five groups of affiliated physicians in the metropolitan Phoenix area, with thirty-one oncology investigators designated to manage patients on clinical trials. The consortium sees an annual new cancer patient population of over 2,300 cases per year. The immediate goals of our GPCCOP include: increased clinical research activities; development and maintenance of a data management support network to maximize quality of data as well as to support NCI's cancer control evaluation; further development of pharmacy resources; and continued development of a broadly based cancer program involving primary care physicians. The consortium has complete facilities and personnel for the treatment of cancer and has already implemented joint cancer control activities, such as physician and nursing patient management guidelines, in addition to the wide range of cancer control activities present within each of the GPCCOP components. The GPCCOP has developed detailed methodology for implementing clinical research activities. We have established a centralized data management system, criterial for protocol selection with assurances of patient accrual, physician patient logs, appropriate staffing to collect data and monitor protocol compliance, mechanisms for research base data transmission, quality control and feedback procedures, pharmacy control according to the requirements specified by the FDA and an IRB liaison committee to interact with individual hospital IRBs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM